首页> 外国专利> process for the manufacture of 9 amp; 11 amp; alpha; beta; - dihalogensteroider of pregnan or androstanrækken.

process for the manufacture of 9 amp; 11 amp; alpha; beta; - dihalogensteroider of pregnan or androstanrækken.

机译:制造9&11&alpha的过程; Beta; -pregnan或androstanrækken的二卤类固醇激素。

摘要

The invention comprises steroids of the formula FORM:0928302/IV(a)/1 and the 1-dehydro- and 19-nor-analogues thereof (wherein B is hydrogen, methyl or, provided that at least one of D, V and Z is other than hydrogen, fluoro; D is hydrogen or alkyl of at most 6 carbon atoms; V is hydrogen, hydroxy, alkanoyloxy of at most 6 carbon atoms, chloro, bromo or methyl; and Z is hydrogen or halogen but is not chlorine or bromine when V is hydrogen or hydroxy and, at the same time, B is hydrogen; provided that, if V is hydrogen, hydroxy or alkanoyloxy, then, unless the compound is a 1-dehydro or a 19-nor compound, at least one of B, D and Z is other than hydrogen) but excludes 17a -hydroxy- 21-fluoro- 4,9(11)-pregnadiene-3,20-dione, its 17-acylates and its 6a -methyl and D 1-6a -methyl derivatives. The invention also comprises 21-chloro- and bromo-19-nor-4,9(11)-pregnatriene-3,20-diones and their 17a -hydroxy derivatives; 21-chloro- and bromo-1,4,9(11)-pregnatriene-3,20-diones, their 17a -hydroxy derivatives and the 6a -fluoro and 6a -methyl derivatives of these compounds; and steroids of the formula FORM:0928302/IV(a)/2 wherein V is alkanoyloxy of at most 6 carbon atoms. They may be prepared by dehydrating 11-hydroxy analogues by, for example, methanesulphonyl chloride or phosphorus oxychloride and pyridine, or concentrated hydrochloric acid in refluxing benzene ether. The 11-hydroxy compounds may in turn be prepared by microbiological hydroxylation or by reduction of 11-ketones, preferably after protection of 3- and/or 20-keto groups, which may subsequently be regenerated. Resulting D 4 compounds may be dehydrogenated to D 1,4-compounds by microbiological or chemical means. 17-Ols may be esterified. In examples (1) 11b -hydroxy-19-nor-4-pregnene-3,20-dione gives the corresponding D 9(11)- compound; (2) 6b -methyl-progesterone is hydroxylated with the organism Curvularia lunata to give 6b -methyl-11b -hydroxy-progesterone, this is dehydrated to the corresponding D 9(11)-compound and this with the organism Corynebacerium simplex gives the D 1-derivative; (3) 6a -methyl-11a -hydroxy-progesterone is dehydrated via the 11-p-toluenesulphonate to the D 9(11)-compound; (4) 21-hydroxy-4,9(11)-pregnadiene-3,20-dione is converted to the 21-tosylate, this to the 21-iodo-compound and this to the 21-fluoro compound; (5) 21-hydroxy-1,4,9(11)- pregnatriene-3,20-dione is prepared by the dehydrogenation method of (2) and is then converted to the 21-iodo and 21-fluoro compounds; (6) 21-hydroxy-19-nor-progesterone is converted to the 21-tosylate, this via the 21-iodo compound to 21-fluoro-19-nor-progesterone, this is 11-hydroxylated to 11b -hydroxy-21-fluoro-19-nor-progesterone and this is dehydrated; (7) the product of (3) is converted to the 21-fluoro-compound via the 21-iodo-compound; (8) 6a -fluoro-11b , 21-dihydroxyprogesterone and methane sulphonyl chloride give 6a -fluoro- 21-hydroxy-4,9(11)-pregnadiene- 3,20-dione 21-methane-sulphonate and this is converted via the 21-iodo compound to the 21-fluoro compound; (9) the products of (7) and (8) are D 1-dehydrogenated; (10) 17a ,21-dihydroxy- 1,4,9(11)-pregnatriene-3,20-dione is prepared by hydrolysis of the 21-acetate and is then converted to 17a -hydroxy-1,4,9(11)-pregnatriene-3,20-dione, from which various 17-esters are prepared; (11) 11b ,17a -dihydroxy-19-nor-progesterone is prepared by hydroxylation of the 11-unsubstituted compound and is then dehydrated to the D 9(11)-compound; (12) 11b ,17a -dihydroxy- 1-allopregnene-3,20-dione 17-acetate is prepared as in (11) and is then dehydrated to the D 9(11)-compound; (13) 17a -methyl- 21-hyroxy- 4,9(11)-pregnadiene-3,20-dione 21-mesylate is prepared from the 11b , 21-diol and mesyl chloride and is then D 9(11)-dehydrated; (14) 11b -hydroxy-17a -bromoprogesterone is prepared by 11b -hydroxylation and is then D 9(11)-dehydrated; (15) 3b -hydroxy-5-pregnene-20-one is converted to 5,17 (20)-pregnadiene-3b ,20-diol diacetate, this is chlorinated to 3b -hydroxy-5a ,6b ,17a -trichloroallopregnane-20-one 3-acetate, this is converted to 3b -hydroxy-17a -chloro-5-pregnen-20-one 3-acetate, this with the organism Flavobacterium dehydrogenans gives 17a -chloro-progesterone, this is hydroxylated to 11b -hydroxy-17a -chloro-progesterone and this is D 9(11)-dehydrated; (16) 17a -hydroxy-21-iodo-4,9(11)-pregnadiene-3,20-dione is prepared from the 21-bromo compound and is converted into various 17-esters; (17) the first product of (13) is converted to the 21-fluoro compound via the 21-iodo compound; (18) the product of (14) is converted to the 21-fluoro compound via the 21-iodo compound; (19) various 17a ,21-substituted- D 4,9(11)-products are D 1-dehydrogenated; (20) 6a -methyl-17a ,21- dihydroxy- 4,9(11)-pregnadiene-3, 20-dione-21-acetate is prepared from 6a -methyl-hydrocortisone acetate and is hydrolysed to the 21-ol, this is converted to the corresponding 21-unsubstituted compound and from this various 17-esters are prepared; (21) 6a -fluoro- 17a -hydroxy- 4,9(11)- pregnadiene-3,20-dione is prepared by D 9(11)-dehydration and is converted to the 17-acetate; (22) 6a -and 6b -fluoro-11b ,17a - dihydroxy-19-norprogesterone 17-acetates are prepared by 11b -hydroxylation and are then converted to the D 9(11)-compounds; (23) 17a -methyl-progesterone 3,20-bis-ethylene ketal is prepared by ketalization, converted to the 5b ,6b - and 5a ,6a -epoxides, the latter converted to 5a -hydroxy- 6b ,17a -diethylallopregnane-3,20-dione, this dehydrated to 6b ,17a -dimethyl-progesterone, this hydroxylated to the 11b -ol, this dehydrated to the D 9(11)-compound and this epimerized to the 6a -methyl compound; (24) the a -epoxide of (23) is converted to 5a -hydroxy-6b -fluoro-17a -methyl-pregnane-3,20-dione, this is dehydrated to 6b -fluoro-17a -methylprogesterone, this is hydroxylated to 6b -fluoro- 11b -hydroxy- 17a -methylprogesterone and this is treated as the 6b -methyl compound in (23); (25) 17a -bromo-progesterone 3,20-bis-ethyleneketal is prepared by ketalization, and converted to the 5a ,6a -epoxide, this is converted to 5a -hydroxy-6b -methyl and 6b -fluoro- 17a -bromo-allopregnane-3,20-diones, these to 6a -methyl-and 6a -fluoro-17a -bromoprogesterones, these to the 11b -hydroxy-compounds and these are D 9(11)-dehydrated; (26) 6a -fluoro-17a ,21-dihydroxy-4,9(11)- pregnadiene-3,20-dione 21-methanesulphonate is prepared from the 21-ol and converted to the 21-fluoro compound via the 21-iodo compound, and 17-esters of these compounds are also prepared; (27) the products of (24) and (25) are converted to the 21-iodo- and 21-fluoro-compounds; (28) the D 1-dehydrogenation of many D 9(11)-steroids of the invention is described; (29) 11a -hydroxy-16a -methylprogesterone is prepared by 11-hydroxylation with the organism Rhizopus nigricans and is converted to the 11-tosylate, and this is converted to the D 9(11)-compound (the 16b -methyl compound is prepared similarly); (30) the products of (29) are converted to the 21-iodo and fluoro compounds; (31) 3b -hydroxy-16a -methyl-5-pregnen-20-one 3-acetate is converted to 3b -hydroxy-5,6- dichloro -16a -methylpregnan-20-one 3-acetate, this to 3b ,17a -dihydroxy-5,6-dichloro- 16a -methylpregnan-20-one, this to 5,6-dichloro- 16a -methyl- 17a -hydroxypregnane-3,20-dione, this to 16a -methyl-17a -hydroxy-5-pregnane- 3,20-dione, this to 16a -methyl-17a -hydroxyprogesterone, this to 11a , 17a -dihydroxy-16a -methyl-progesterone, this to the 11-tosylate, and this to the D 9(11)-compound and 17-esters thereof; (32) 3b -hydroxy-5,16-pregnadiene-20-one and ethyl magnesium iodide give 3b -hydroxy-16a -ethyl-5-pregnen-20-one, this is converted to 16a -ethylprogesterone, this to 11a -hydroxy-16a -ethylprogesterone and this to the 11-tosylate and then the D 9(11)-compound; and (33) 11a ,17a -dihydroxy- 16a -methyl-progesterone 3,20-bis-ethylene-ketal is prepared from the dione and converted to 5a ,6a -epoxy- 11a ,17a -dihydroxy-16a -methylpregnane- 3, 20-dione 3,20-bis-ethylene-ketal, this is converted to 5a ,11a ,17a -trihydroxy- 6b ,16a -dimethylpregnane- 3,20-dione, this to 6b ,16a -dimethyl-11a -17a -dihydroxyprogesterone, this is epimerized to the 6a -methyl-compound, this is converted to the 11-tosylate and this to the D 9(11)-compound and its 17-acetate.
机译:本发明包括式的类固醇及其1-脱氢和19-正类似物(其中B是氢,甲基或,如果D,V中至少一个是Z是氢或氟以外的氢; Z是氢或碳数最多6个的烷基; V是氢,羟基,碳原子数最多6个的烷酰氧基,氯,溴或甲基; Z是氢或卤素,但不是当V为氢或羟基且同时B为氢时,氯或溴;如果V为氢,羟基或烷酰氧基,则除非该化合物为1-脱氢或19-nor化合物,否则B,D和Z中的至少一个不是氢),但不包括17a-羟基-21-氟-4,9(11)-孕二烯-3,20-二酮,其17-酰化物及其6a-甲基和D 1 -6a-甲基衍生物。本发明还包括21-氯-和溴--19-nor-4,9(11)-孕三烯-3,20-二酮及其17a-羟基衍生物。这些化合物的21-氯-和溴-1,4,9(11)-孕三烯-3,20-二酮,它们的17a-羟基衍生物以及这些化合物的6a-氟和6a-甲基衍生物;和式的甾族化合物,其中V是至多6个碳原子的烷酰氧基。它们可以通过用例如甲磺酰氯或氯氧化磷和吡啶或浓盐酸在回流的苯醚中使11-羟基类似物脱水来制备。该11-羟基化合物可依次通过微生物羟基化或通过还原11-酮来制备,优选在保护3-和/或20-酮基团之后,随后可将其再生。可以通过微生物或化学手段将所得的D 4化合物脱氢为D 1,4-化合物。 17-Ol可能被酯化。在实施例(1)中,11b-羟基-19-正-4-戊烯-3,20-二酮得到相应的D 9(11)-化合物; (2)6b-甲基-孕酮与弯曲菌弯曲,得到6b-甲基-11b-羟基-孕酮,将其脱水成相应的D 9(11)-化合物,再与Corynebacerium simplex结合,得到D 1-导数(3)通过11-对甲苯磺酸酯将6a-甲基-11a-羟基孕酮脱水为D 9(11)化合物; (4)将21-羟基-4,9(11)-孕二烯-3,20-二酮转化为21-甲苯磺酸酯,将其转化为21-碘化合物,并将其转化为21-氟化合物; (5)通过(2)的脱氢方法制备21-羟基-1,4,9(11)-孕三烯-3,20-二酮,然后将其转化为21-碘和21-氟化合物; (6)21-羟基-19-正黄体酮通过21-碘化合物转化为21-甲苯磺酸酯,转化为21-氟-19-正黄体酮,被11-羟基化为11b-羟基-21-。氟-19-孕酮,脱水。 (7)将(3)的产物通过21-碘化合物转化为21-氟化合物; (8)6a-氟-11b,21-二羟基黄体酮和甲烷磺酰氯产生6a-氟-21-羟基-4,9(11)-孕二烯-3,20-二酮21-甲烷磺酸酯,并通过21-碘化合物为21-氟化合物; (9)将(7)和(8)的产物进行D 1-脱氢。 (10)通过21-乙酸酯的水解制备17a,21-21-二羟基-1,4,9(11)-孕三烯-3,20-二酮,然后将其转化为17a-羟基-1,4,9(11) )-孕三烯-3,20-二酮,可制得各种17-酯; (11)11b,17a-二羟基-19-正黄体酮是通过将11-未取代的化合物羟基化而制备的,然后脱水成D 9(11)-化合物; (12)按(11)的方法制备11b,17a-二羟基-1-1-戊二烯-3,20-二酮17-乙酸酯,然后脱水成D 9(11)-化合物; (13)由11b,21-二醇和甲磺酰氯制备17a-甲基-21-羟基-4,9(11)-孕二烯-3,20-二酮21-甲磺酸酯,然后将其D 9(11)脱水; (14)将11b-羟基-17a-溴代孕酮通过11b-羟基化制备,然后将其D 9(11)脱水。 (15)3b-羟基-5-孕烯-20-一转化为5,17(20)-孕二烯-3b,20-二醇二乙酸酯,将其氯化为3b-羟基-5a,6b,17a-三氯allopregnane-20 -一个3-醋酸盐,将其转化为3b-羟基-17a-氯5-孕烯20-一个3-醋酸盐,与生物脱氢黄杆菌产生17a-氯-孕酮,将其羟基化为11b-羟基- 17a-氯孕酮,它是D 9(11)脱水的; (16)由21-溴化合物制备17a-羟基-21-碘-4,9(11)-孕二烯-3,20-二酮,并转化成各种17-酯; (17)将(13)的第一产物通过21-碘化合物转化为21-氟化合物。 (18)将(14)的产物通过21-碘化合物转化为21-氟化合物; (19)将各种17a,21-取代的D 4,9(11)-产物进行D 1-脱氢; (20)由6a-甲基-氢化可的松乙酸酯制备6a-甲基-17a,21-二羟基-4,9(11)-孕二烯-3,20-二酮-21-乙酸酯,并将其水解为21-ol,将其转化为相应的21-未取代的化合物,并由此制备出各种17-酯; (21)通过D 9(11)-脱水制备6a-氟-17a-羟基-4,9(11)-孕二烯-3,20-二酮,并转化为17-乙酸酯。 (22)通过11b-羟基化制备6a-和6b-氟-11b,17a-二羟基-19-正孕酮17-乙酸酯,然后将其转化为D 9(11)化合物; (23)通过缩酮化制备17a-甲基孕酮3,20-双-乙烯缩酮,将其转化为5b,6b-和5a,6a-环氧,后者转化为5a-羟基-6b,17a-二乙基allopregnane-3 ,20-二酮,脱水成6b,17a-二甲基-孕酮,羟基化成11b-ol,脱水成D 9(11)-化合物,差向异构体成6a-甲基化合物。 (24)将(23)的α-环氧化物转化为5a-羟基-6b-氟-17a-甲基-孕烯-3,20-二酮,将其脱水成6b-氟-17a-甲基孕酮,将其羟基化为6b-氟-11b-羟基-17a-甲基孕酮,在(23)中作为6b-甲基化合物处理。 (25)通过缩酮化制备17a-溴-孕酮3,20-双-乙烯缩酮,并将其转化为5a,6a-环氧,将其转化为5a-羟基-6b-甲基和6b-氟-17a-溴- Allopregnane-3,20-diones,分别为6a-甲基-和6a-fluoro-17a-溴孕酮,它们与11b-羟基化合物,且经D 9(11)脱水; (26)由21-醇制备6a-氟-17a,21-二羟基-4,9(11)-孕二烯-3,20-二酮21-甲磺酸酯,并通过21-碘转化为21-氟化合物。化合物,还制备了这些化合物的17个酯; (27)将(24)和(25)的产物转化为21-碘和21-氟化合物; (28)描述了许多本发明的D 9(11)-类固醇的D 1-脱氢; (29)11a-羟基-16a-甲基孕酮是通过与黑生根霉菌11-羟基化制备的,并转化为11-甲苯磺酸酯,然后转化为D 9(11)-化合物(16b-甲基化合物为类似地准备); (30)将(29)的产物转化为21-碘和氟化合物; (31)将3b-羟基-16a-甲基-5-孕烯-20-3-乙酸酯转化为3b-羟基-5,6-二氯-16a-甲基pregnan-20-3-乙酸酯,将此转化为3b,17a。 -二羟基-5,6-二氯-16a-甲基pregnan-20-one,这是5,6-二氯-16a-甲基-17a-羟基孕烯-3,20-二酮,这是16a-甲基-17a-羟基-5 -pregnane- 3,20-dione,这是16a-甲基-17a-羟基孕酮,这是11a,17a -dihydroxy-16a-甲基黄体酮,这是11-甲苯磺酸酯,这是D 9(11)-化合物及其17酯; (32)3b-羟基-5,16-孕二烯-20-一和碘化乙基镁产生3b-羟基-16a-乙基-5-孕-20-一,将其转化为16a-乙基孕酮,将此转化为11a-羟基-16a-乙基孕酮和11-甲苯磺酸酯,然后是D 9(11)-化合物; (33)由二酮制备11a,17a-二羟基-16a-甲基孕酮3,20-双-乙烯-缩酮,并转化为5a,6a-环氧-11a,17a-二羟基-16a-甲基孕烯-3, 20-二酮3,20-双乙烯-缩酮,将其转化为5a,11a,17a-三羟基-6b,16a-二甲基戊烯-3,20-二酮,其转化为6b,16a-二甲基-11a -17a-二羟基黄体酮,它被差向异构体为6a-甲基化合物,被转化为11-甲苯磺酸酯,然后被转化为D 9(11)-化合物及其17-乙酸酯。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号